You are here:

Category - Session 04: Screening, Assessment & Diagnosis of Dementia

Articles

Brief cognitive screening instruments: an update
Canadian Study of Health and Aging: study methods and prevalence of dementia
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
CCCDTD5: Individual and community-based psychosocial and other non-pharmacological interventions to support persons living with dementia and their caregivers
CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia
Diagnosis and Treatment of Dementia
Diagnosis and Treatment of Dementia: 2. Diagnosis
Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia
Implementing Routine Cognitive Screening of Older Adults in Primary Care: Process and Impact on Physician Behavior
Mild Cognitive Impairment: Clinical Characterization and Outcome
National Guidelines for Seniors' Mental Health: The Assessment and Treatment of Delirium
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
Recommendations on the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
Rising Tide: The Impact of Dementia of Canadian Society
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective
Toronto dementia research alliance (TDRA) dementia clinical-research platform: An example of research embedded into clinical care
+ 8 Articles
Show all articles